Clinical trials: Metastatic Malignant Neoplasm in the Bone Marrow

Metastatic Ewing Sarcoma, Metastatic Malignant Neoplasm in the Bone

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma

• Active, not recruiting
• Age: Up to 50 years
• Phase 3
• Injection or infusion
• Surgery or procedure
• Results posted

This randomized phase III trial studies how well combination chemotherapy with or without ganitumab works in treating patients with newly diagnosed Ewing sarcoma that has spread to other parts of the body.

Conditions

Metastatic Ewing Sarcoma, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Bone Marrow, Metastatic Malignant Neoplasm in the Lung

Trial name

NCT02306161

Testing

Cyclophosphamide, Doxorubicin, Doxorubicin Hydrochloride

Where

314 sites in United States, Canada and 1 more

Volunteers

312 people

Sponsor

National Cancer Institute (NCI)